Home/Pipeline/Borvo EVAC™ System

Borvo EVAC™ System

Chronic Subdural Hematoma (SDH) Drainage

ApprovedActive

Key Facts

Indication
Chronic Subdural Hematoma (SDH) Drainage
Phase
Approved
Status
Active
Company

About Borvo Medical

Borvo Medical is a private, commercial-stage medical device company targeting the growing market for chronic subdural hematoma (cSDH) treatment. Its core innovation is the FDA-cleared Borvo EVAC™ system, which leverages advanced 3D-printed titanium fabrication and ergonomic design to offer a more efficient, less invasive tool for hematoma evacuation, often used in conjunction with middle meningeal artery (MMA) embolization. Early clinical data from five medical centers shows a 100% success rate in initial cases, positioning the company to capitalize on the rapid adoption of MMA procedures. The company is led by experienced medtech entrepreneurs and is backed by a specialized venture firm.

View full company profile